skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
We are delighted to announce the finalists for the 2018 Clinical and Research Excellence Awards:

Best in Health Economics and Outcomes Research

Bracket, Pfizer & ICON, Study of BYOD ePRO Equivalence Across Different Device Types

EMD Serono, Global Evidence & Value Development MAVENCLAD

Merck KGaA, Darmstadt, Germany, Merkel Cell Carcinoma (MCC) Observational Study for Historic Comparison


Best Patient-Focused Technological Development

Bracket, Bracket Mobile ePRO

CRF Health, TrialConsent eCOA and eConsent hybrid technology



ERT, Voice Assistant Data Capture

HealthiVibe, HealthiPerspectives


Best Sponsor-Focused Technological Development

Bioclinica, SMART Submit

CluePoints, RBM and CSM – Miracle Pills for the Clinical R&D Industry

ERT, Centralized Clinical Trial Analytics Solution

goBalto, Activate Configuration Designer


Medidata Solutions, Medidata Strategic Monitoring

Oracle, Oracle Health Sciences Clinical One Platform

Medidata Clinical Partnership of the Year
Sponsored by Medidata Solutions

Cytel and Biogen

Inovio, GBM-001 Team: Inovio and Regeneron

Merck KGaA, Darmstadt, Germany and Avillion       

Myovant Sciences and Takeda Pharmaceuticals          

Novartis and Amgen           

Novartis and University of Pennsylvania

Theravance Biopharma and Mylan  


Clinical Research Team of the Year
Sponsored by Oracle Health Sciences

AMAG & ICON Adult Iron Deficiency Trial

Celgene & ICON CAR T Core Team

Otsuka Digital Medicine Team

Paratek Pharmaceuticals, Omadacycline Clinical Development Team


Clinical Trial Result of the Year
Sponsored by Cytel

Ardelyx, T3MPO-2 Phase 3 Study

Boehringer Ingelheim, EMPA-REG OUTCOME trial

Eli Lilly and Company, Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine

F. Hoffmann-La Roche, ALEX clinical trial

Novartis, KYMRIAH™ (tisagenlecleucel) suspension for intravenous infusion

Paratek Pharmaceuticals, Phase 3 Clinical Trial Results for a Novel Antibiotic


Excellence in Rare Disease Drug Development

Alnylam Pharmaceuticals, Hereditary ATTR (hATTR) amyloidosis

Atlantic Healthcare, Alicaforsen – accelerated recruitment to a pivotal Phase 3 study in IBD pouchitis

Deciphera Pharmaceuticals, DCC-2618 for Gastrointestinal Stromal Tumors (GIST)

Global Blood Therapeutics (GBT), voxelotor (GBT440)

Otsuka Pharmaceutical Development & Commercialization, Autosomal Dominant Polycystic Kidney Disease (ADPKD) Tolvaptan Team

Rhythm Pharmaceuticals, Setmelanotide for Rare Genetic Disorders of Obesity


Most Innovative Clinical Trial Design
Sponsored by Syneos Health

Almac Clinical Technologies

Forty Seven          

Global Blood Therapeutics (GBT), voxelotor (GBT440)

Nestlé Health Science in collaboration with Cytel, Dysphagia Detection System (DDS) Device

Otsuka Pharmaceutical Development & Commercialization, Autosomal Dominant Polycystic Kidney Disease (ADPKD) Tolvaptan Team


Most Successful Early Phase Research (Preclinical & Phase I)

Altasciences Clinical Research, Full-service innovative cannabis research solutions

AveXis, Phase 1 Clinical Trial of AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

Catalyst Biosciences, Achievement of Stable Normal Factor IX Blood Levels in a Preclinical Subcutaneous Dosing Model

Forty Seven          

Viking Therapeutics, VK2809 for Glycogen Storage Disease Ia


Marquee Award for R&D Excellence


BioMarin Pharmaceuticals

Merck & Co.




Vertex Pharmaceuticals



Trophies are designed and manufactured by